Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease

Neuroscience Letters

Volumn 211, Issue 1, 1996, Pages 13-16

  Mogi, Makio ^a   Harada, Minoru ^a   Narabayashi, Hirotaro ^b   Inagaki, Hirofumi ^c   Minami, Masayasu ^c   Nagatsu, Toshiharu ^d  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Epidermal growth factor ; Interleukin 1 ; Interleukin 2; Interleukin 4; Interleukin 6; Juvenile parkinsonism; Parkinson's disease; Transforming growth factor ; Tumor necrosis factor ; Ventricular cerebrospinal fluid

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL;

EID: 0030582991     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12706-3     Document Type: Article

References (33)

1. [1] Beutler, B. and Cerami, A., Tumor necrosis, cachexia, shock, and inflammation: a common mediator, Annu. Rev. Biochem., 57 (1988) 505-518.
2. [2] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72 (1976) 248-254.
3. [3] Carpenter, G. and Cohen, S.A., Epidermal growth factor, Annu. Rev. Biochem., 48 (1979) 193-216.
4. [4] Carvey, P.M., Ptak, L.R., Nath, S.T., Sierens, D.K., Mufson, E.J., Goetz, C.G. and Klawans, H.L., Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures, Exp. Neurol., 120 (1993) 149-152.
5. [5] Chung, I.Y. and Benveniste, E.N., Tumor necrosis factor-α production by astrocytes: induction by lipopolysaccharide, IFN-γ and IL-1β, J. Immunol., 144 (1990) 2999-3007.
6. [6] Furukawa, Y., Kondo, T., Nishi, K., Yokochi, F. and Narabayashi, H., Total biopterin levels in the ventricular CSF of patients with Parkinson's disease: a comparison between akineto-rigid and tremor types, J. Neurol. Sci., 103 (1991) 232-237.
7. [7] Gershanik, O.S. and Leist, A., Juvenile onset Parkinson's disease, Adv. Neurol., 45 (1986) 213-216.
8. [8] Gibb, W.R. and Lees, A.J., A comparison of clinical and pathological features of young-and old-onset Parkinson's disease, Neurology, 38 (1988) 1402-1406.
9. [9] Greenfield, S.A., Cell death in Parkinson's disease. In K.F. Tipton (Ed.), Essays in Biochemistry, Vol. 27, Portland Press, London, UK, 1992, pp. 103-118.
10. [10] Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K. and Nagatsu, T., Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene, Nature Genet., 8 (1994) 236-242.
11. [11] Ichinose, H., Ohye, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K. and Nagatsu, T., GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation, Neurosci. Lett., 196 (1995) 5-8.
12. [12] Ichinose, H., Ohye, T., Yokochi, M., Fujita, K. and Nagatsu, T., GTP cyclohydrolase I activity in mononuclear blood cells in juvenile parkinsonism, Neurosci. Lett., 190 (1995) 140-142.
13. [13] Inagaki, H., Katoh, M., Kurosawa-Ohsawa, K. and Tanaka, S., A new sandwich enzyme-linked immunosorbent assay (ELISA) for transforming growth factor α (TGF-α) based upon conformational modification by antibody binding, J. Immunol. Methods, 128 (1990) 27-37.
14. [14] Javoy-Agid, F., Ruberg, M., Taquet, H., Bokobza, B., Agid, Y., Caspar, P., Berger, B., N'Guyen-Legros, J., Alvarez, C., Gray, F., Escourolle, R., Scatton, B. and Rouquier, L., Biochemical neuropathology of Parkinson's disease, Adv. Neurol., 40 (1984) 189-198.
15. [15] Katsuura, M. and Tanaka, S., Topographic analysis of human epidermal growth factor by monospecific antibodies and synthetic peptides, J. Biochem., 106 (1989) 87-92.
16. [16] Kusahara, T., Yagisawa, H., Yamashita, K., Yamaguchi, Y. and Akigama, Y., IL-1 induces proliferation and IL-6 mRNA expression in a human astrocytoma cell line: positive and negative modulation by chorela toxin and cAMP, Biochem. Biophys. Res. Commun., 167 (1990) 1242-1248.
17. [17] Lindholm, D., Heumann, R., Meyer, M. and Thoenen, H., Interleukin-1 regulates synthesis of nerve growth factor in nonneuronal cells of rat sciatic nerve, Nature, 330 (1987) 658-659.
18. [18] Martin, W.E., Resch, J.A. and Baker, A.B., Juvenile parkinsonism, Arch. Neurol., 25 (1971) 494-500.
19. [19] Mogi, M., Harada, M., Kondo, T., Narabayashi, H., Riederer, P. and Nagatsu, T., Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease, Neurosci. Lett., 193 (1995) 129-132.
20. [20] Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M. and Nagatsu, T., Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients, Neurosci. Lett., 180 (1994) 147-150.
21. [21] Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K. and Nagatsu T., Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients, Neurosci. Lett., 165 (1994) 208-210.
22. [22] Mogi, M., Kojima, K. and Nagatsu, T., Detection of inactive or less active forms of tyrosine hydroxylase in human adrenals by a sandwich enzyme immunoassay, Anal. Biochem., 138 (1984) 125-132.
23. [23] Morrison, R.S., Kornblum, H.I., Leslie, F.M. and Bradshaw, R.A., Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor, Science, 238 (1987) 72-75.
24. [24] Narabayashi, H., Yokochi, M., Iizuka, R. and Nagatsu, T., Juvenile parkinsonism. In P.J. Vinken, G.W., Bruyn and H.L., Klawans (Eds.), Handbook of Clinical Neurology, Vol. 5 (49), Elsevier, Amsterdam, 1986, pp. 153-165.
25. [25] Perschak, H., Amsler, U., Vischer, A., Siegfried, J. and Cuenod, M., Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders, Hum. Neurobiol., 6 (1987) 191-194.
26. [26] Synder, S.H., Parkinson's disease, fresh factors to consider, Nature, 350 (1991) 195-196.
27. [27] Sternberg, E.M., Monokines, lymphokines and brain. In J.M. Cruse and R.E. Lewis Jr. (Eds), The Years in Immunology 1988: Immunoregulatory Cytokines and Cell Growth, Karger, Basel, 1988, pp. 205-217.
28. [28] Van Snick, J., Interleukin-6: and overview, Annu. Rev. Immunol., 8 (1990) 253-278.
29. [29] Weiss, R., Promising protein for Parkinson's, Science, 260 (1993) 1072-1073.
30. [30] Yoshida, K. and Gage, F.H., Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes, Brain Res., 538 (1991) 118-126.
31. [31] Yokochi, M., Narabayashi, H., Iizuka, R. and Nagatsu, T., Juvenile parkinsonism: some clinical, pharmacological, and neuropathological aspects, Adv. Neurol., 40 (1984) 407-413.
32. [32] Yokochi, M. and Narabayashi, H., Clinical characteristics of juvenile parkinsonism. In F.C. Rose and R. Capildeo (Eds.), Research Progress in Parkinson's Disease, Pitman Medical, Tunbridge Wells, UK, 1981, pp. 35-39.
33. [33] Yu, S.J., Lo, E.S., Cochran, E.J., Lin, D.H., Faselis, C.J., Klawans, H.L. and Carvey, P.M., Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture, Exp. Neurol., 126 (1994) 15-24.